Table 3 Lymphocyte count (10⁹/L) in the experimental groups at the experimental periods

I

3.92 ± 0.05^Ca

4.09 ± 0.16^Aa

3.93 ± 0.08^BCa

4.31 ± 0.37^Ba

4.6 ± 0.23^Ba

II

3.79 ± 0.15^BCa

3.73 ± 0.13^Aa

3.78 ± 0.28^Ba

3.9 ± 0.23^ABa

4.34 ± 0.27^Ba

 % of change^P1

(− 3.27)

(− 8.83)

(− 3.86)

(− 9.56)

(− 5.66)

III

3.48 ± 0.24^ABCa

3.79 ± 0.31^Aa

3.61 ± 0.099^Ba

3.69 ± 0.214^ABa

3.3 ± 0.14^Aa

 % of change^P1

(− 11.28)

(− 7.29)

(− 8.30)

(− 14.50)

(− 28.46)

IV

3.69 ± 0.36^BCa

3.82 ± 0.17^Aab

4.55 ± 0.34^Cb

4.17 ± 0.13 ^ABab

4.63 ± 0.16^Bb

 % of change^P1

(− 5.85)

(− 6.53)

(15.82)

(− 3.19)

(0.51)

V

3.13 ± 0.22^ABa

3.47 ± 0.57^Aa

2.68 ± 0.17^Aa

3.38 ± 0.39^Aa

2.99 ± 0.08^Aa

 % of change^P1

(− 20.20)

(− 15.10)

(− 31.84)

(− 21.56)

(− 34.85)

VI

2.94 ± 0.17^Aa

3.68 ± 0.09^Ab

4.01 ± 0.17^BCbc

4.54 ± 0.13^Bc

4.34 ± 0.3^Bc

 % of change^P2

(− 5.96)

(5.82)

(49.86)

(34.10)

(44.78)